Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Enbrel (Etanercept) Biosimilar market was valued at US$ 1283.1 million in 2022 and is projected to reach US$ 1732.5 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Syringe Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Enbrel (Etanercept) Biosimilar include Samsung Bioepis, Novartis, 3s Bio and Lupin, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.
This report aims to provide a comprehensive presentation of the global market for Enbrel (Etanercept) Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enbrel (Etanercept) Biosimilar. This report contains market size and forecasts of Enbrel (Etanercept) Biosimilar in global, including the following market information:
Global Enbrel (Etanercept) Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enbrel (Etanercept) Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Enbrel (Etanercept) Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enbrel (Etanercept) Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enbrel (Etanercept) Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enbrel (Etanercept) Biosimilar Market Segment Percentages, by Type, 2022 (%)
Syringe
Pen
Global Enbrel (Etanercept) Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enbrel (Etanercept) Biosimilar Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Other
Global Enbrel (Etanercept) Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enbrel (Etanercept) Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enbrel (Etanercept) Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enbrel (Etanercept) Biosimilar revenues share in global market, 2022 (%)
Key companies Enbrel (Etanercept) Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Enbrel (Etanercept) Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Samsung Bioepis
Novartis
3s Bio
Lupin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enbrel (Etanercept) Biosimilar, market overview.
Chapter 2: Global Enbrel (Etanercept) Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Enbrel (Etanercept) Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enbrel (Etanercept) Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enbrel (Etanercept) Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Enbrel (Etanercept) Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enbrel (Etanercept) Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enbrel (Etanercept) Biosimilar Overall Market Size
2.1 Global Enbrel (Etanercept) Biosimilar Market Size: 2022 VS 2029
2.2 Global Enbrel (Etanercept) Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Enbrel (Etanercept) Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Enbrel (Etanercept) Biosimilar Players in Global Market
3.2 Top Global Enbrel (Etanercept) Biosimilar Companies Ranked by Revenue
3.3 Global Enbrel (Etanercept) Biosimilar Revenue by Companies
3.4 Global Enbrel (Etanercept) Biosimilar Sales by Companies
3.5 Global Enbrel (Etanercept) Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Enbrel (Etanercept) Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Enbrel (Etanercept) Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enbrel (Etanercept) Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Enbrel (Etanercept) Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Enbrel (Etanercept) Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Enbrel (Etanercept) Biosimilar Market Size Markets, 2022 & 2029
4.1.2 Syringe
4.1.3 Pen
4.2 By Type - Global Enbrel (Etanercept) Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Enbrel (Etanercept) Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Enbrel (Etanercept) Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Enbrel (Etanercept) Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Enbrel (Etanercept) Biosimilar Sales & Forecasts
4.3.1 By Type - Global Enbrel (Etanercept) Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Enbrel (Etanercept) Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Enbrel (Etanercept) Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Enbrel (Etanercept) Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Enbrel (Etanercept) Biosimilar Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Enbrel (Etanercept) Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Enbrel (Etanercept) Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Enbrel (Etanercept) Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Enbrel (Etanercept) Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Enbrel (Etanercept) Biosimilar Sales & Forecasts
5.3.1 By Application - Global Enbrel (Etanercept) Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Enbrel (Etanercept) Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Enbrel (Etanercept) Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Enbrel (Etanercept) Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Enbrel (Etanercept) Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Enbrel (Etanercept) Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Enbrel (Etanercept) Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Enbrel (Etanercept) Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Enbrel (Etanercept) Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Enbrel (Etanercept) Biosimilar Sales & Forecasts
6.3.1 By Region - Global Enbrel (Etanercept) Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Enbrel (Etanercept) Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Enbrel (Etanercept) Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Enbrel (Etanercept) Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Enbrel (Etanercept) Biosimilar Sales, 2018-2029
6.4.3 US Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.4.4 Canada Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.4.5 Mexico Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Enbrel (Etanercept) Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Enbrel (Etanercept) Biosimilar Sales, 2018-2029
6.5.3 Germany Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5.4 France Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5.5 U.K. Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5.6 Italy Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5.7 Russia Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.5.9 Benelux Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Enbrel (Etanercept) Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Enbrel (Etanercept) Biosimilar Sales, 2018-2029
6.6.3 China Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.6.4 Japan Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.6.5 South Korea Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.6.7 India Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Enbrel (Etanercept) Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Enbrel (Etanercept) Biosimilar Sales, 2018-2029
6.7.3 Brazil Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.7.4 Argentina Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Enbrel (Etanercept) Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Enbrel (Etanercept) Biosimilar Sales, 2018-2029
6.8.3 Turkey Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.8.4 Israel Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
6.8.6 UAE Enbrel (Etanercept) Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Samsung Bioepis
7.1.1 Samsung Bioepis Company Summary
7.1.2 Samsung Bioepis Business Overview
7.1.3 Samsung Bioepis Enbrel (Etanercept) Biosimilar Major Product Offerings
7.1.4 Samsung Bioepis Enbrel (Etanercept) Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Samsung Bioepis Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Enbrel (Etanercept) Biosimilar Major Product Offerings
7.2.4 Novartis Enbrel (Etanercept) Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 3s Bio
7.3.1 3s Bio Company Summary
7.3.2 3s Bio Business Overview
7.3.3 3s Bio Enbrel (Etanercept) Biosimilar Major Product Offerings
7.3.4 3s Bio Enbrel (Etanercept) Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 3s Bio Key News & Latest Developments
7.4 Lupin
7.4.1 Lupin Company Summary
7.4.2 Lupin Business Overview
7.4.3 Lupin Enbrel (Etanercept) Biosimilar Major Product Offerings
7.4.4 Lupin Enbrel (Etanercept) Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Lupin Key News & Latest Developments
8 Global Enbrel (Etanercept) Biosimilar Production Capacity, Analysis
8.1 Global Enbrel (Etanercept) Biosimilar Production Capacity, 2018-2029
8.2 Enbrel (Etanercept) Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Enbrel (Etanercept) Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enbrel (Etanercept) Biosimilar Supply Chain Analysis
10.1 Enbrel (Etanercept) Biosimilar Industry Value Chain
10.2 Enbrel (Etanercept) Biosimilar Upstream Market
10.3 Enbrel (Etanercept) Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enbrel (Etanercept) Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
